Literature DB >> 20181480

Centronuclear myopathies: a widening concept.

Norma Beatriz Romero1.   

Abstract

Centronuclear myopathies (CNM) are a group of congenital myopathies classically defined by the presence of an abnormally high number of muscle fibres with nuclei organised in rows in the central part of the fibre. Over recent years there have been important advances in the knowledge of the genetic bases of the three main forms of CNM: the X-linked recessive form or myotubular myopathy (XLMTM) with severe neonatal phenotype, caused by mutations in the MTM1 gene; the classical autosomal dominant forms with mild, moderate or severe phenotypes caused by mutations in the DNM2 gene; and an autosomal recessive form presenting severe and moderate phenotypes caused by mutations in the BIN1 gene. Although at present the histopathological distinction between these described forms of CNM seems well established, these three genes do not explain all the cases of CNM and there still exist an important number of genetically unresolved cases with prominent myonuclei internalisation and centralisation. This mini-review lays emphasis on the particular histopathological abnormalities associated with specific gene mutations, the high significance of establishing a distinction between nuclear centralisation (i.e. the presence of one nucleus at the geometric centre of the fibre) and nuclear internalisation (i.e. one or more nuclei anywhere inside the sarcoplasm) for CNM categorisation, and demonstrates how additional structural alterations within muscle fibres are a useful criterion for suggesting or discarding DNM2-, BIN1- or MTM1-related CNM. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20181480     DOI: 10.1016/j.nmd.2010.01.014

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  93 in total

1.  Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness.

Authors:  Belinda S Cowling; Anne Toussaint; Leonela Amoasii; Pascale Koebel; Arnaud Ferry; Laurianne Davignon; Ichizo Nishino; Jean-Louis Mandel; Jocelyn Laporte
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype.

Authors:  Christopher R Pierson; Ashley N Dulin-Smith; Ashley N Durban; Morgan L Marshall; Jordan T Marshall; Andrew D Snyder; Nada Naiyer; Jordan T Gladman; Dawn S Chandler; Michael W Lawlor; Anna Buj-Bello; James J Dowling; Alan H Beggs
Journal:  Hum Mol Genet       Date:  2011-11-07       Impact factor: 6.150

3.  Clinical utility gene card for: Centronuclear and myotubular myopathies.

Authors:  Valérie Biancalana; Alan H Beggs; Soma Das; Heinz Jungbluth; Wolfram Kress; Ichizo Nishino; Kathryn North; Norma B Romero; Jocelyn Laporte
Journal:  Eur J Hum Genet       Date:  2012-05-23       Impact factor: 4.246

4.  A mutation associated with centronuclear myopathy enhances the size and stability of dynamin 2 complexes in cells.

Authors:  Nicholas G James; Michelle A Digman; Justin A Ross; Barbara Barylko; Lei Wang; Jinhui Li; Yan Chen; Joachim D Mueller; Enrico Gratton; Joseph P Albanesi; David M Jameson
Journal:  Biochim Biophys Acta       Date:  2013-09-07

5.  Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice.

Authors:  Nathalie Danièle; Christelle Moal; Laura Julien; Martina Marinello; Thibaud Jamet; Samia Martin; Alban Vignaud; Michael W Lawlor; Ana Buj-Bello
Journal:  J Neuropathol Exp Neurol       Date:  2018-04-01       Impact factor: 3.685

6.  DNM2 mutations in Chinese Han patients with centronuclear myopathy.

Authors:  Pengfei Lin; Xinhong Liu; Dandan Zhao; Tingjun Dai; Huamin Wu; Yaoqin Gong; Chuanzhu Yan
Journal:  Neurol Sci       Date:  2016-02-23       Impact factor: 3.307

7.  TAN lines: a novel nuclear envelope structure involved in nuclear positioning.

Authors:  G W Gant Luxton; Edgar R Gomes; Eric S Folker; Howard J Worman; Gregg G Gundersen
Journal:  Nucleus       Date:  2011 May-Jun       Impact factor: 4.197

8.  Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations.

Authors:  F Hanisch; T Müller; A Dietz; M Bitoun; W Kress; J Weis; G Stoltenburg; S Zierz
Journal:  J Neurol       Date:  2011-01-09       Impact factor: 4.849

Review 9.  Recent advances using zebrafish animal models for muscle disease drug discovery.

Authors:  Lisa Maves
Journal:  Expert Opin Drug Discov       Date:  2014-06-14       Impact factor: 6.098

10.  Clinical and Pathological Features of Korean Patients with DNM2-Related Centronuclear Myopathy.

Authors:  Young-Eun Park; Young-Chul Choi; Jong-Suk Bae; Chang-Hoon Lee; Hyang-Suk Kim; Jin-Hong Shin; Dae-Seong Kim
Journal:  J Clin Neurol       Date:  2014-01-06       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.